Adaptive selection of a prion strain conformer corresponding to established North American CWD during propagation of novel emergent Norwegian strains in mice expressing elk or deer prion protein.
Journal
PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
15
03
2021
accepted:
24
06
2021
revised:
05
08
2021
pubmed:
27
7
2021
medline:
25
2
2023
entrez:
26
7
2021
Statut:
epublish
Résumé
Prions are infectious proteins causing fatal, transmissible neurodegenerative diseases of animals and humans. Replication involves template-directed refolding of host encoded prion protein, PrPC, by its infectious conformation, PrPSc. Following its discovery in captive Colorado deer in 1967, uncontrollable contagious transmission of chronic wasting disease (CWD) led to an expanded geographic range in increasing numbers of free-ranging and captive North American (NA) cervids. Some five decades later, detection of PrPSc in free-ranging Norwegian (NO) reindeer and moose marked the first indication of CWD in Europe. To assess the properties of these emergent NO prions and compare them with NA CWD we used transgenic (Tg) and gene targeted (Gt) mice expressing PrP with glutamine (Q) or glutamate (E) at residue 226, a variation in wild type cervid PrP which influences prion strain selection in NA deer and elk. Transmissions of NO moose and reindeer prions to Tg and Gt mice recapitulated the characteristic features of CWD in natural hosts, revealing novel prion strains with disease kinetics, neuropathological profiles, and capacities to infect lymphoid tissues and cultured cells that were distinct from those causing NA CWD. In support of strain variation, PrPSc conformers comprising emergent NO moose and reindeer CWD were subject to selective effects imposed by variation at residue 226 that were different from those controlling established NA CWD. Transmission of particular NO moose CWD prions in mice expressing E at 226 resulted in selection of a kinetically optimized conformer, subsequent transmission of which revealed properties consistent with NA CWD. These findings illustrate the potential for adaptive selection of strain conformers with improved fitness during propagation of unstable NO prions. Their potential for contagious transmission has implications for risk analyses and management of emergent European CWD. Finally, we found that Gt mice expressing physiologically controlled PrP levels recapitulated the lymphotropic properties of naturally occurring CWD strains resulting in improved susceptibilities to emergent NO reindeer prions compared with over-expressing Tg counterparts. These findings underscore the refined advantages of Gt models for exploring the mechanisms and impacts of strain selection in peripheral compartments during natural prion transmission.
Identifiants
pubmed: 34310663
doi: 10.1371/journal.ppat.1009748
pii: PPATHOGENS-D-21-00572
pmc: PMC8341702
doi:
Substances chimiques
PrPSc Proteins
0
Prion Proteins
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1009748Subventions
Organisme : NIAID NIH HHS
ID : P01 AI077774
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS109376
Pays : United States
Déclaration de conflit d'intérêts
I have read the journal’s policy and the authors of this manuscript have the following competing interests: CS is a Founder, Chief Scientific Officer and Member of the Board of Directors of Amprion Inc, a biotechnology company that focuses on the commercial use of PMCA and RT-QuIC for high-sensitivity detection of misfolded protein aggregates including prion diseases. The University of Texas Health Science Center at Houston has licensed patents and patent applications to Amprion. The remaining authors declare that they have no conflicts of interest with the contents of this article.
Références
Proc Natl Acad Sci U S A. 2019 Jun 18;116(25):12478-12487
pubmed: 31147460
Proc Natl Acad Sci U S A. 2019 Dec 16;:
pubmed: 31843908
J Virol. 1994 Dec;68(12):7859-68
pubmed: 7966576
Philos Trans R Soc Lond B Biol Sci. 1994 Mar 29;343(1306):405-11
pubmed: 7913758
Emerg Infect Dis. 2014 May;20(5):833-7
pubmed: 24751215
Cell. 1989 Dec 1;59(5):847-57
pubmed: 2574076
J Biol Chem. 2007 Oct 12;282(41):30022-8
pubmed: 17709374
Vet Res. 2019 Jul 31;50(1):59
pubmed: 31366372
J Wildl Dis. 2019 Oct;55(4):970-972
pubmed: 30920905
PLoS Pathog. 2013 Mar;9(3):e1003219
pubmed: 23505374
Am J Pathol. 2003 Dec;163(6):2585-93
pubmed: 14633630
Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):6028-33
pubmed: 24711410
Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):646-50
pubmed: 15647363
Lancet. 1997 Jul 19;350(9072):219-20
pubmed: 9250209
Gene. 1997 Oct 15;199(1-2):283-6
pubmed: 9358067
Science. 2010 Feb 12;327(5967):869-72
pubmed: 20044542
Genes Dev. 1992 Jul;6(7):1213-28
pubmed: 1628828
J Vet Med Sci. 2002 Sep;64(9):855-8
pubmed: 12399615
Nat Med. 1997 Jul;3(7):750-5
pubmed: 9212101
Science. 2010 May 28;328(5982):1154-8
pubmed: 20466881
J Biol Chem. 2020 Apr 10;295(15):4985-5001
pubmed: 32111742
Lancet. 1999 Jul 24;354(9175):317-23
pubmed: 10440324
J Gen Virol. 1987 Jul;68 ( Pt 7):1875-81
pubmed: 3110370
Science. 1996 Dec 20;274(5295):2079-82
pubmed: 8953038
J Toxicol Environ Health A. 2009;72(17-18):1025-9
pubmed: 19697236
Science. 2012 Jan 27;335(6067):472-5
pubmed: 22282814
Cell. 1986 Aug 1;46(3):417-28
pubmed: 2873895
PLoS Pathog. 2017 Mar 29;13(3):e1006298
pubmed: 28355274
Nat Protoc. 2012 Jun 28;7(7):1397-409
pubmed: 22743831
Mol Med. 1994 Nov;1(1):19-30
pubmed: 8790598
Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):12005-10
pubmed: 20547859
Emerg Infect Dis. 2018 Dec;24(12):2210-2218
pubmed: 30457526
Science. 2006 Feb 24;311(5764):1117
pubmed: 16439622
Vet Res. 2016 Sep 15;47(1):88
pubmed: 27641251
J Biol Chem. 2020 Jul 24;295(30):10420-10433
pubmed: 32513872
J Gen Virol. 2008 Feb;89(Pt 2):598-608
pubmed: 18198392
J Virol. 2006 Sep;80(18):9104-14
pubmed: 16940522
Science. 2004 Dec 3;306(5702):1793-6
pubmed: 15539564
Lancet Neurol. 2006 May;5(5):393-8
pubmed: 16632309
Emerg Infect Dis. 2009 Sep;15(9):1366-76
pubmed: 19788803
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1141-1146
pubmed: 28096357
J Biol Chem. 2011 Mar 4;286(9):7490-5
pubmed: 21209079
Neuron. 2002 Jun 13;34(6):921-32
pubmed: 12086640
Cell. 1990 Nov 16;63(4):673-86
pubmed: 1977523
PLoS One. 2012;7(6):e39055
pubmed: 22723928
Methods Mol Biol. 2017;1658:219-252
pubmed: 28861793
PLoS One. 2011;6(5):e20563
pubmed: 21655184
Top Curr Chem. 2011;305:79-99
pubmed: 21769720
PLoS Pathog. 2008 Aug 29;4(8):e1000139
pubmed: 18769716
Emerg Infect Dis. 2018 Jun;24(6):1029-1036
pubmed: 29652245
Science. 2007 Nov 9;318(5852):930-6
pubmed: 17991853
J Neurosci. 2005 Aug 31;25(35):7944-9
pubmed: 16135751
mBio. 2019 Jul 23;10(4):
pubmed: 31337719
Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9936-40
pubmed: 7937921
Prion. 2020 Dec;14(1):1-10
pubmed: 31852336
J Wildl Dis. 2007 Apr;43(2):309-14
pubmed: 17495319
J Vet Med Sci. 2013;75(8):1107-10
pubmed: 23708962
J Gen Virol. 2010 Oct;91(Pt 10):2651-7
pubmed: 20610667
J Cell Biol. 2010 Feb 22;188(4):515-26
pubmed: 20156965
Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7620-4
pubmed: 1354357
J Virol. 2010 Aug;84(16):8322-6
pubmed: 20519392
J Virol. 2015 Dec;89(24):12362-73
pubmed: 26423950
Cell. 1995 Oct 6;83(1):79-90
pubmed: 7553876
J Virol. 2004 Dec;78(23):13345-50
pubmed: 15542685
Biochem Biophys Res Commun. 2002 Jun 7;294(2):280-6
pubmed: 12051707
Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):304-9
pubmed: 19073920
Protein Sci. 2001 Apr;10(4):854-63
pubmed: 11274476
J Infect Dis. 2021 Jan 27;:
pubmed: 33502474
J Vet Med Sci. 2005 Aug;67(8):753-9
pubmed: 16141661
J Wildl Dis. 2006 Jul;42(3):640-5
pubmed: 17092895
Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):11169-74
pubmed: 25034251
J Mol Biol. 2008 Nov 7;383(2):306-12
pubmed: 18773909
Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):31417-31426
pubmed: 33229531
J Biol Chem. 2012 Oct 26;287(44):37219-32
pubmed: 22948149
Science. 1982 Apr 9;216(4542):136-44
pubmed: 6801762
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3812-7
pubmed: 11904434
Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3498-503
pubmed: 22331873
Lancet. 1996 Apr 6;347(9006):921-5
pubmed: 8598754
Nat Commun. 2017 Jan 23;8:14170
pubmed: 28112164
Emerg Infect Dis. 2009 May;15(5):696-703
pubmed: 19402954
J Gen Virol. 2018 May;99(5):753-758
pubmed: 29580373
J Virol. 2015 Sep;89(18):9524-31
pubmed: 26157118
PLoS Pathog. 2013 Oct;9(10):e1003692
pubmed: 24204258